Prevalence of Synovitis in Patients With Haemophilia A
Launched by UNIVERSITY HOSPITAL, BONN · Apr 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Prevalence of Synovitis in Patients With Haemophilia A," aims to understand how common a condition called synovitis is among adult men with haemophilia A. Synovitis is the inflammation of the lining of the joints, which can cause pain and swelling, and is often seen in patients with haemophilia A, a genetic disorder that affects blood clotting. The study is currently looking for participants who are 18 years or older and have moderate to severe haemophilia A. Eligible participants must have a detailed medical history that includes information about their treatment and any bleeding events from the past year.
If you decide to join this study, you will be helping researchers learn more about how haemophilia A impacts joint health. It’s important to note that the trial is only open to men who do not have other bleeding disorders that could interfere with the study. Participants will need to provide written consent, and they can expect to undergo assessments related to their condition. This trial is a step towards improving care and treatment for those living with haemophilia A.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Participants (≥ 18 years old) suffering from moderate or severe haemophilia A, also with inhibitor or joint replacement
- • Complete documentation of hemophilia severity, treatment history (past 12 months), and bleeding events (past 12 months), inhibitor status (at time of enrollment and in past medical history)
- • Submitted written consent to participate in the study
- Exclusion Criteria:
- • Patients suffering from other bleeding disorders conflicting with the research question
- • Patients in clinical studies with investigational drugs
About University Hospital, Bonn
The University Hospital Bonn is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution leverages its extensive expertise in various medical disciplines to investigate novel therapies and enhance patient outcomes. With a commitment to ethical standards, patient safety, and rigorous scientific methodologies, the University Hospital Bonn collaborates with multidisciplinary teams and partners to drive forward-thinking solutions in medicine, ultimately contributing to the global body of clinical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bonn, Nrw, Germany
Patients applied
Trial Officials
Andreas C Strauss, PD Dr. med.
Principal Investigator
University Hospital, Bonn
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported